Prader-Willi Syndrome

Why Shares of Soleno Therapeutics Are Booming on Tuesday
Motley Fool
Tue, 09/26/23 - 09:46 pm
Soleno
Prader-Willi Syndrome
DCCR
Acadia gives once-rejected Prader-Willi drug a second chance
BioPharma Dive
Wed, 06/14/23 - 06:40 pm
Acadia Pharmaceuticals
Prader-Willi Syndrome
clinical trials
ACP-101
Carbetocin
FDA has no appetite for Levo’s metabolic disorder drug and asks for new trial
MedCity News
Wed, 01/19/22 - 11:11 am
Levo Therapeutics
Prader-Willi Syndrome
FDA
LV-101
FDA adcomm votes 12-1 against Levo Therapeutics' nasal spray for a disorder that causes insatiable hunger
Endpoints
Fri, 11/5/21 - 09:45 am
FDA
Levo Therapeutics
Prader-Willi Syndrome
Soleno slims down
EP Vantage
Tue, 06/9/20 - 12:14 pm
Soleno
diazoxide choline
Prader-Willi Syndrome
Bringing social media listening into R&D
Pharmaforum
Mon, 03/23/20 - 11:27 am
social media
artificial intelligence
Prader-Willi Syndrome
Upcoming events – Soleno has a date with Destiny while Arbutus tries again
EP Vantage
Fri, 02/28/20 - 10:42 am
Solena
diazoxide choline
Prader-Willi Syndrome
Arbutus
hepatitis B
ARB-729
Why Insys Therapeutics Inc Is Up Double Digits for the Second Straight Day
Motley Fool
Wed, 01/3/18 - 11:55 pm
INSYS Therapeutics
CBD
Prader-Willi Syndrome
After axing a top drug, Millendo bags a PhII replacement with biotech buyout
Endpoints
Wed, 12/20/17 - 11:07 pm
Millendo Therapeutics
livoletide
Prader-Willi Syndrome
M&A
Alizé Pharma SAS
After axing a top drug, Millendo bags a PhII replacement with biotech buyout
Endpoints
Wed, 12/20/17 - 11:07 pm
Millendo Therapeutics
livoletide
Prader-Willi Syndrome
M&A
Alizé Pharma SAS
Zafgen Inc Surges on Positive One-Of-A-Kind Drug Trial Results
Bidness, ETC
Wed, 01/20/16 - 08:43 am
Zafgen
clinical trials
beloranib
Prader-Willi Syndrome
Zafgen says FDA will still review data from trial despite patient death
Bizjournals.com
Thu, 10/22/15 - 10:01 am
Zafgen
FDA
clinical trials
belornib
Prader-Willi Syndrome
Zafgen finally breaks its silence, says it's probing death of a patient
Fierce Biotech
Wed, 10/14/15 - 02:20 pm
Zafgen
Prader-Willi Syndrome
beloranib
Pfizer, OrbiMed back $40M Rhythm round for rare genetic disease R&D
Fierce Biotech
Sun, 08/16/15 - 10:30 am
Pfizer
OrbiMed
Rhythm Pharmaceuticals
Prader-Willi Syndrome
Zafgen Opens A New Front In Its Obesity Strategy: Prader-Willi Syndrome
Forbes
Thu, 01/16/14 - 09:27 am
obesity
Zafgen
Prader-Willi Syndrome
beloranib